A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL

Clinical trial NCT04496349 · RECRUITING

Trial details

NCT number: NCT04496349
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T-Prolymphocytic Leukemia Non-Hodgkins Lymphoma

Start date: 2021-07-12
Primary completion: 2026-05-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.